CARE vs NFBK

For growth investors, Northfield Bancorp, Inc.

(NFBK) is the stronger pick with 13. 9% revenue growth year-over-year, versus 6. 2% for Carter Bankshares, Inc. (CARE). Carter Bankshares, Inc. (CARE) offers the better valuation at 18. 7x trailing P/E (4. 8x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Carter Bankshares, Inc.

(CARE) is the cheapest at 18. 7x versus Northfield Bancorp, Inc. at 19. 5x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x.

Over the past 5 years, Carter Bankshares, Inc.

(CARE) delivered a total return of +88. 0%, compared to -0. 3% for Northfield Bancorp, Inc. (NFBK). Over 10 years, the gap is even starker: CARE returned +111. 1% versus NFBK's +19. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Carter Bankshares, Inc.

(CARE) is the lower-risk stock at 0. 56β versus Northfield Bancorp, Inc. 's 1. 00β — meaning NFBK is approximately 77% more volatile than CARE relative to the S&P 500. On balance sheet safety, Carter Bankshares, Inc. (CARE) carries a lower debt/equity ratio of 43% versus 108% for Northfield Bancorp, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Northfield Bancorp, Inc.

(NFBK) is pulling ahead at 13. 9% versus 6. 2% for Carter Bankshares, Inc. (CARE). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to -16. 3% for Northfield Bancorp, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Carter Bankshares, Inc.

(CARE) is the more profitable company, earning 12. 3% net margin versus 11. 9% for Northfield Bancorp, Inc. — meaning it keeps 12. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NFBK leads at 16. 1% versus 15. 7% for CARE. At the gross margin level — before operating expenses — CARE leads at 61. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Carter Bankshares, Inc.

(CARE) trades at 4. 8x forward P/E versus 10. 4x for Northfield Bancorp, Inc. — 5. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NFBK: 3. 2% to $14. 50.

In this comparison, NFBK (3.

7% yield) pays a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Northfield Bancorp, Inc.

(NFBK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), 3. 7% yield). Both have compounded well over 10 years (NFBK: +19. 1%, CARE: +111. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CARE is a small-cap quality compounder stock; NFBK is a small-cap income-oriented stock. NFBK pays a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.